Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/20/2017 04/21/2017 04/24/2017 04/25/2017 04/26/2017 Date
1.66(c) 1.67(c) 1.66(c) 1.66(c) 1.85(c) Last
455 789 603 464 276 426 380 862 807 874 Volume
+1.22% +0.60% -0.60% 0.00% +11.45% Change
More quotes
Financials ($)
Sales 2017 -
EBIT 2017 -23,5 M
Net income 2017 -25,6 M
Debt 2017 -
Yield 2017 -
Sales 2018 13,0 M
EBIT 2018 -21,7 M
Net income 2018 -22,3 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 11,8x
Capitalization 153 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
03/28 CATALYST PHARMACEUTICALS INC : Catalyst Pharmaceuticals and ZIOPHARM Oncology Bo..
03/15 Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial..
03/15 CATALYST PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
03/15 NETWORKNEWSBREAKS – CATALYST P : CPRX) Shares Rally on Positive Data from ..
03/15 CATALYST PHARMACEUTICALS, INC. (NASD : CPRX) Files An 8-K Other Events
03/15 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
03/15 Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored ..
03/10 Catalyst Pharmaceuticals to Present at the 29th Annual ROTH Conference
03/09 Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference ..
02/27 Catalyst Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement..
More news
Sector news : Bio Therapeutic Drugs
12:35a AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
04/18DJACTELION : J&J Lifts Forecast on Actelion Tie-Up--Update
04/18DJJOHNSON & JOHNSON : Lifts Forecast on Actelion Tie-Up
More sector news : Bio Therapeutic Drugs
Latest Tweets
04/10Want the latest analyst ratings on $CPRX $INFO $CBE $CX $CSII? Get Them Deliv.. 
03/29Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% -  
03/27$CPRX nice breakout  
03/27$CPRX bit more HODs, nearing $2 what a move so far. 
03/27% movers today are : Up $SYX $WFT $PKD $SBBGL $RT $APOPW $IPXL $ZIOP $RGLS $..
1
More tweets
Qtime:15
News from SeekingAlpha
03/16 HEALTHCARE - TOP 5 GAINERS / LOSERS : 20
03/16 Catalyst Pharmaceutical Partners' (CPRX) CEO Pat McEnany on Q4 2016 Results -..
03/15 Catalyst Pharmaceutical beats by $0.02
03/15 Midday Gainers / Losers
03/15 HEALTHCARE- TOP 5 GAINERS / LOSERS A : 15 pm
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,25 $
Spread / Average Target 130%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Patrick J. McEnany Chairman, President & Chief Executive Officer
Steven R. Miller Chief Operating & Scientific Officer
Alicia Grande Chief Financial Officer, Treasurer & VP
Gary Ingenito Chief Medical Officer & Head-Regulatory Affairs
Philip H. Coelho Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CATALYST PHARMACEUTICA..76.19%153
AMGEN, INC.12.58%121 135
CELGENE CORPORATION8.16%97 401
GILEAD SCIENCES, INC.-4.73%89 180
REGENERON PHARMACEUTIC..1.42%39 475
ACTELION LTD26.44%30 212
More Results